Linden Thomas Advisory Services LLC Sells 190 Shares of Innospec Inc. $IOSP

Linden Thomas Advisory Services LLC lessened its position in Innospec Inc. (NASDAQ:IOSP) by 1.6% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 11,736 shares of the specialty chemicals company’s stock after selling 190 shares during the quarter. Linden Thomas Advisory Services LLC’s holdings in Innospec were worth $987,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of IOSP. Nuveen LLC bought a new position in Innospec in the 1st quarter worth $42,966,000. Financial Harvest LLC bought a new position in Innospec in the 1st quarter worth $41,107,000. Brown Advisory Inc. bought a new position in Innospec in the 1st quarter worth $31,212,000. Victory Capital Management Inc. grew its position in Innospec by 20.0% in the 1st quarter. Victory Capital Management Inc. now owns 1,106,482 shares of the specialty chemicals company’s stock worth $104,839,000 after purchasing an additional 184,262 shares during the last quarter. Finally, Millennium Management LLC grew its position in Innospec by 8,176.5% in the 1st quarter. Millennium Management LLC now owns 170,414 shares of the specialty chemicals company’s stock worth $16,147,000 after purchasing an additional 168,355 shares during the last quarter. Institutional investors own 96.64% of the company’s stock.

Analyst Upgrades and Downgrades

IOSP has been the topic of several research analyst reports. Zacks Research upgraded shares of Innospec from a “strong sell” rating to a “hold” rating in a research report on Monday, October 6th. Weiss Ratings lowered shares of Innospec from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Saturday. Finally, Wall Street Zen lowered shares of Innospec from a “buy” rating to a “hold” rating in a research report on Sunday, October 19th. One investment analyst has rated the stock with a Strong Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold”.

Innospec Stock Performance

Shares of Innospec stock opened at $76.31 on Monday. The firm’s 50-day simple moving average is $80.55 and its 200-day simple moving average is $84.18. Innospec Inc. has a twelve month low of $73.39 and a twelve month high of $128.35. The firm has a market cap of $1.89 billion, a P/E ratio of 97.83 and a beta of 1.04.

Innospec (NASDAQ:IOSP) last issued its earnings results on Tuesday, August 5th. The specialty chemicals company reported $1.26 earnings per share for the quarter, beating the consensus estimate of $1.17 by $0.09. Innospec had a net margin of 1.08% and a return on equity of 10.89%. The business had revenue of $439.70 million for the quarter, compared to analyst estimates of $440.70 million. During the same period in the previous year, the business earned $1.39 EPS. The firm’s revenue was up 1.1% on a year-over-year basis. On average, equities analysts forecast that Innospec Inc. will post 6.18 earnings per share for the current fiscal year.

Innospec Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.